Since its injectable medication Stelara, which generated over $10 billion in sales last year, is up against fierce competition from less expensive competitors, J&J has been developing more practical psoriasis treatment choices
.jpg "ICRA sees steady growth ahead for Indian pharma industry")
India's pharmaceutical industry is set to record healthy revenue growth of 7-9 per cent in FY26, even as challenges in the United States market continue to weigh on performance, noted rating agency ICRA in its latest sector outlook
New data from the HS-OBTAIN phase 2a study (NCT05849922) that has been released today at the EADV 2025 Congress in Paris shows that the investigational therapy brivekimig has most significantly improved the region of skin disease in patients with...
Stryker, a company that is known worldwide for its medical technologies, has made its presence known in India for the research and development area by inaugurating a new facility of 140,000 sq. ft. in Whitefield, Bengaluru.
India is positioned as an emerging leader in robotic-assisted cardiac surgery, according to international specialists at the Society of Minimally Invasive Cardiovascular and Thoracic Surgeons of India's annual conference (SMICTSI 2025)
Elsevier has revealed a comprehensive AI platform for researchers to reshape how academic and corporate sectors conduct work. The goal of this advanced platform is to empower scientists to transition quickly from insights to real-world...
Bayer announced the launch of Bayer Co.Lab AdVenture, a major extension of their global life sciences incubator network meant to connect biotechnological startups with vanguard venture capital firms worldwide.
AstraZeneca announced today positive top-line results from the Phase III TULIP-SC study, assessing the subcutaneous administration of Saphnelo (anifrolumab) in patients with systemic lupus erythematosus (SLE).The interim analysis met the...
one of the largest private sector healthcare services companies in India, and Medtronic, a global leader in healthcare technology
ZyVet Animal Health, a part of Zydus Pharmaceuticals (USA), and the leader in affordable generic animal medicines, has just announced the debut of the first FDA-approved generic phenylpropanolamine hydrochloride tablets.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")